학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 17건 | 목록
1~20
Academic Journal
Eijsvogel, Pepijn P.N.M.; Gorbenko, Andriy A.; Tardiff, Dan F.; Skupien, Michelle; Rhodes, Ken; Scannevin, Robert H.; Yavuz, Yalcin; van Brummelen, Emilie M.J.; Robertson, Brigitte; Kremer, Philip H.C.; Groeneveld, Geert Jan
Biomarkers in Neuropsychiatry. 13
Academic Journal
Sonneveld, Pieter, MD, PhD; Moreau, Philippe, MD; Dimopoulos, Meletios A., MD; Quach, Hang, MBBS (Hons), FRACP, FRCPA, MD; Ho, P. Joy, MBBS(Syd), DPhil (Oxon), FRACP, FRCPA, FFSC(RCPA); Beksac, Meral, MD; Hulin, Cyrille, MD; Antonioli, Elisabetta, MD, PhD; Leleu, Xavier, MD, PhD; Mangiacavalli, Silvia, MD; Perrot, Aurore, MD, PhD; Cavo, Michele, MD; Belotti, Angelo, MD; Broijl, Annemiek, MD, PhD; Gay, Francesca, MD, PhD; Mina, Roberto, MD; Nijhof, Inger S., MD, PhD; van de Donk, Niels W.C.J., MD, PhD; Katodritou, Eirini, MD, PhD; Schjesvold, Fredrik, MD, PhD; Sureda Balari, Anna, MD, PhD; Rosiñol, Laura, MD, PhD; Cavo, Michel, MD, PhD; Roeloffzen, Wilfried, MD, PhD; Driessen, Christoph, MD; Vangsted, Annette, MD, DMSc; Einsele, Hermann, MD; Spencer, Andrew, MBBS, FRCPA, FRACP, DM; Hajek, Roman, MD, PhD; Jurczyszyn, Artur, MD, PhD; Lonergan, Sarah, BSc; Liu, Yanfang, MD; Wang, Jianping, PhD; Vieyra, Diego, MSc, PhD; van Brummelen, Emilie M.J., PharmD, PhD; Vanquickelberghe, Veronique, PhD; de Boer, Carla J., PhD; Carson, Robin, MD, BA; Bladé, Joan, MD, PhD; Boccadoro, Mario, MD; Rodriguez-Otero, Paula, MD, PhD
Clinical Lymphoma, Myeloma and Leukemia. 24:S550-S551
Academic Journal
Dimopoulos, Meletios A., MD; Sonneveld, Pieter, MD, PhD; Rodriguez-Otero, Paula, MD, PhD; Quach, Hang, MBBS (Hons), FRACP, FRCPA, MD; Ho, P. Joy, MBBS(Syd), DPhil(Oxon), FRACP, FRCPA, FFSC(RCPA); Beksac, Meral, MD; Hulin, Cyrille, MD; Antonioli, Elisabetta, MD, PhD; Leleu, Xavier, MD, PhD; Mangiacavalli, Silvia, MD; Perrot, Aurore, MD, PhD; Cavo, Michele, MD; Belotti, Angelo, MD; Broijl, Annemiek, MD, PhD; Gay, Francesca, MD, PhD; Mina, Roberto, MD; Nijhof, Inger S., MD, PhD; van de Donk, Niels W.C.J., MD, PhD; Katodritou, Eirini, MD, PhD; Schjesvold, Fredrik, MD, PhD; Sureda Balari, Anna, MD, PhD; Rosiñol, Laura, MD, PhD; Cavo, Michel, MD, PhD; Roeloffzen, Wilfried, MD, PhD; Driessen, Christoph, MD; Vangsted, Annette, MD, DMSc; Einsele, Hermann, MD; Spencer, Andrew, MBBS, FRCPA, FRACP, DM; Hajek, Roman, MD, PhD; Jurczyszyn, Artur, MD, PhD; Lonergan, Sarah, BSc; Liu, Yanfang, MD; Wang, Jianping, PhD; Vieyra, Diego, MSc, PhD; van Brummelen, Emilie M.J., PharmD, PhD; Vanquickelberghe, Veronique, PhD; de Boer, Carla J., PhD; Carson, Robin, MD, BA; Bladé, Joan, MD, PhD; Boccadoro, Mario, MD; Moreau, Philippe, MD
Clinical Lymphoma, Myeloma and Leukemia. 24:S547-S548
Academic Journal
Sonneveld, Pieter, MD, PhD; Moreau, Philippe, MD; Dimopoulos, Meletios A., MD; Quach, Hang, MBBS (Hons), FRACP, FRCPA, MD; Joy Ho, P., MBBS(Syd), DPhil (Oxon), FRACP, FRCPA, FFSC(RCPA); Beksac, Meral, MD; Hulin, Cyrille, MD; Antonioli, Elisabetta, MD, PhD; Leleu, Xavier, MD, PhD; Mangiacavalli, Silvia, MD; Perrot, Aurore, MD, PhD; Cavo, Michele, MD; Belotti, Angelo, MD; Broijl, Annemiek, MD, PhD; Gay, Francesca, MD, PhD; Mina, Roberto, MD; Nijhof, Inger S., MD, PhD; van de Donk, Niels W.C.J., MD, PhD; Katodritou, Eirini, MD, PhD; Schjesvold, Fredrik, MD, PhD; Sureda Balari, Anna, MD, PhD; Rosiñol, Laura, MD, PhD; Delforge, Michel, MD, PhD; Roeloffzen, Wilfried, MD, PhD; Driessen, Christoph, MD; Vangsted, Annette, MD, DMSc; Einsele, Hermann, MD; Spencer, Andrew, MBBS, FRCPA, FRACP, DM; Hajek, Roman, MD, PhD; Jurczyszyn, Artur, MD, PhD; Lonergan, Sarah, BSc; Liu, Yanfang, MD; Wang, Jianping, PhD; Vieyra, Diego, MSc, PhD; van Brummelen, Emilie M.J., PharmD, PhD; Vanquickelberghe, Veronique, PhD; Sitthi-Amorn, Anna, MD; de Boer, Carla J., PhD; Carson, Robin, MD, BA; Bladé, Joan, MD, PhD; Boccadoro, Mario, MD; Rodriguez-Otero, Paula, MD, PhD
Clinical Lymphoma, Myeloma and Leukemia. 24:S236-S236
Academic Journal
Thijssen, Eva ; den Heijer, Jonas M. ; Puibert, David ; van Brummelen, Emilie M.J. ; Naranda, Tatjana ; Groeneveld, Geert Jan
In Parkinsonism and Related Disorders April 2022 97:84-90
Academic Journal
Dimopoulos, Meletios A., MD; Sonneveld, Pieter, MD, PhD; Rodriguez-Otero, Paula, MD, PhD; Quach, Hang, MBBS (Hons), FRACP, FRCPA, MD; Joy Ho, P., MBBS(Syd), DPhil(Oxon), FRACP, FRCPA, FFSC(RCPA); Beksac, Meral, MD; Hulin, Cyrille, MD; Antonioli, Elisabetta, MD, PhD; Leleu, Xavier, MD, PhD; Mangiacavalli, Silvia, MD; Perrot, Aurore, MD, PhD; Cavo, Michele, MD; Belotti, Angelo, MD; Broijl, Annemiek, MD, PhD; Gay, Francesca, MD, PhD; Mina, Roberto, MD; Nijhof, Inger S., MD, PhD; van de Donk, Niels W.C.J., MD, PhD; Katodritou, Eirini, MD, PhD; Schjesvold, Fredrik, MD, PhD; Sureda Balari, Anna, MD, PhD; Rosiñol, Laura, MD, PhD; Delforge, Michel, MD, PhD; Roeloffzen, Wilfried, MD, PhD; Driessen, Christoph, MD; Vangsted, Annette, MD, DMSc; Einsele, Hermann, MD; Spencer, Andrew, MBBS, FRCPA, FRACP, DM; Hajek, Roman, MD, PhD; Jurczyszyn, Artur, MD, PhD; Lonergan, Sarah, BSc; Liu, Yanfang, MD; Wang, Jianping, PhD; Vieyra, Diego, MSc, PhD; van Brummelen, Emilie M.J., PharmD, PhD; Vanquickelberghe, Veronique, PhD; Sitthi-Amorn, Anna, MD; de Boer, Carla J., PhD; Carson, Robin, MD, BA; Bladé, Joan, MD, PhD; Boccadoro, Mario, MD; Moreau, Philippe, MD
Clinical Lymphoma, Myeloma and Leukemia. 24:S235-S235
Academic Journal
Verdijk, Pauline ; van der Plas, Johan L. ; van Brummelen, Emilie M.J. ; Jeeninga, Rienk E. ; de Haan, Cornelis A.M. ; Roestenberg, Meta ; Burggraaf, Jacobus ; Kamerling, Ingrid M.C.
In Vaccine 3 September 2020 38(39):6088-6095
Academic Journal
van Brummelen, Emilie M.J.; Huijberts, Sanne; van Herpen, Carla; Desar, Ingrid; Opdam, Frans; van Geel, Robin; Marchetti, Serena; Steeghs, Neeltje; Monkhorst, Kim; Thijssen, Bas; Rosing, Hilde; Huitema, Alwin; Beijnen, Jos; Bernards, Rene; Schellens, Jan
The Oncologist. April, 2021, Vol. 26 Issue 4, p290, 6 p.
Academic Journal
Sonneveld, Pieter ; Dimopoulos, Meletios A. ; Boccadoro, Mario ; Quach, Hang ; Ho, Phoebe Joy ; Beksac, Meral ; Hulin, Cyrille ; Antonioli, Elisabetta ; Leleu, Xavier ; Mangiacavalli, Silvia ; Perrot, Aurore ; Cavo, Michele ; Belotti, Angelo ; Broijl, Annemiek ; Gay, Francesca ; Mina, Roberto ; Nijhof, Inger S. ; van de Donk, Niels W.C.J. ; Katodritou, Eirini ; Schjesvold, Fredrik ; Sureda Balari, Anna ; Rosiñol Dachs, Laura ; Delforge, Michel ; Roeloffzen, Wilfried ; Driessen, Christoph ; Vangsted, Annette ; Einsele, Hermann ; Spencer, Andrew ; Hajek, Roman ; Jurczyszyn, Artur ; Lonergan, Sarah ; Liu, Yanfang ; Wang, Jianping ; van Brummelen, Emilie M.J. ; Vanquickelberghe, Veronique ; Sitthi-Amorn, Anna ; de Boer, Carla J. ; Carson, Robin ; Katz, Eva G. ; Gries, Katharine S. ; Song, Jiaqi ; Ho, Kai Fai ; Rodríguez-Otero, Paula ; Bladé, Joan ; Moreau, Philippe
In Blood 5 November 2024 144 Supplement 1:2000-2000
Academic Journal
Sonneveld, Pieter ; Dimopoulos, Meletios A. ; Boccadoro, Mario ; Quach, Hang ; Ho, P. Joy ; Beksac, Meral ; Hulin, Cyrille ; Antonioli, Elisabetta ; Leleu, Xavier ; Mangiacavalli, Silvia ; Perrot, Aurore ; Cavo, Michele ; Belotti, Angelo ; Broijl, Annemiek ; Gay, Francesca ; Mina, Roberto ; Nijhof, Inger S. ; van de Donk, Niels W.C.J ; Katodritou, Eirini ; Schjesvold, Fredrik ; Sureda Balari, Anna ; Rosiñol, Laura ; Delforge, Michel ; Roeloffzen, Wilfried ; Silzle, Tobias ; Vangsted, Annette ; Einsele, Hermann ; Spencer, Andrew ; Hajek, Roman ; Jurczyszyn, Artur ; Lonergan, Sarah ; Ahmadi, Tahamtan ; Liu, Yanfang ; Wang, Jianping ; Vieyra, Diego ; van Brummelen, Emilie M.J. ; Vanquickelberghe, Veronique ; Sitthi-Amorn, Anna ; de Boer, Carla J. ; Carson, Robin ; Rodríguez Otero, Paula ; Bladé, Joan ; Moreau, Philippe
In Blood 21 November 2023 142 Supplement 2
Review
oncologist. 21(10):1260-1268
Academic Journal
Academic Journal
Academic Journal
Hope S. Rugo; Jean-Pierre Delord; Seock-Ah Im; Patrick A. Ott; Sarina A. Piha-Paul; Philippe L. Bedard; Jasgit Sachdev; Christophe Le Tourneau; Emilie M.J. van Brummelen; Andrea Varga; Roberto Salgado; Sherene Loi; Sanatan Saraf; Dina Pietrangelo; Vassiliki Karantza; Antoinette R. Tan
Clinical Cancer Research. 24:2804-2811
Academic Journal
Pepijn P.N.M. Eijsvogel; Andriy A. Gorbenko; Dan F. Tardiff; Michelle Skupien; Ken Rhodes; Robert H. Scannevin; Yalcin Yavuz; Emilie M.J. van Brummelen; Brigitte Robertson; Philip H.C. Kremer; Geert Jan Groeneveld
Biomarkers in Neuropsychiatry, Vol 13, Iss, Pp 100132-(2025)
Academic Journal
Frenel, Jean-Sebastien; Le Tourneau, Christophe; O'Neil, Bert; Ott, Patrick A.; Piha-Paul, Sarina A.; Gomez-Roca, Carlos; van Brummelen, Emilie M.J.; Rugo, Hope S.; Thomas, Shari; Saraf, Sanatan; Rangwala, Reshma; Varga, Andrea
Academic Journal
Hsu C; Chiun Hsu, National Taiwan University Hospital, Graduate Institute of Oncology, National Taiwan University College of Medicine, and National Taiwan University Cancer Center, Taipei, Taiwan, Republic of China; Se-Hoon Lee, Seoul National University Hospital, Seoul, South Korea; Samuel Ejadi, Virginia G. Piper Cancer Center, Scottsdale, AZ; Roger B. Cohen, University of Pennsylvania, Philadelphia, PA; Janice M. Mehnert, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Alain Algazi, University of California, San Francisco, San Francisco, CA; Sanatan Saraf, Pradeep Thanigaimani, and Jonathan D. Cheng, Merck & Co., Inc., Kenilworth, NJ; Caroline Even, Gustave Roussy, Villejuif; Christophe Le Tourneau, Institut Curie, Paris; Christophe Le Tourneau, INSERM U900 Research Unit, Saint-Cloud, France; Emilie M.J. van Brummelen, Netherlands Cancer Institute, Amsterdam, the Netherlands; and Aaron R. Hansen, Princess Margaret Cancer Centre, Toronto, ON, Canada.; Lee SH; Chiun Hsu, National Taiwan University Hospital, Graduate Institute of Oncology, National Taiwan University College of Medicine, and National Taiwan University Cancer Center, Taipei, Taiwan, Republic of China; Se-Hoon Lee, Seoul National University Hospital, Seoul, South Korea; Samuel Ejadi, Virginia G. Piper Cancer Center, Scottsdale, AZ; Roger B. Cohen, University of Pennsylvania, Philadelphia, PA; Janice M. Mehnert, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Alain Algazi, University of California, San Francisco, San Francisco, CA; Sanatan Saraf, Pradeep Thanigaimani, and Jonathan D. Cheng, Merck & Co., Inc., Kenilworth, NJ; Caroline Even, Gustave Roussy, Villejuif; Christophe Le Tourneau, Institut Curie, Paris; Christophe Le Tourneau, INSERM U900 Research Unit, Saint-Cloud, France; Emilie M.J. van Brummelen, Netherlands Cancer Institute, Amsterdam, the Netherlands; and Aaron R. Hansen, Princess Margaret Cancer Centre, Toronto, ON, Canada.; Ejadi S; Chiun Hsu, National Taiwan University Hospital, Graduate Institute of Oncology, National Taiwan University College of Medicine, and National Taiwan University Cancer Center, Taipei, Taiwan, Republic of China; Se-Hoon Lee, Seoul National University Hospital, Seoul, South Korea; Samuel Ejadi, Virginia G. Piper Cancer Center, Scottsdale, AZ; Roger B. Cohen, University of Pennsylvania, Philadelphia, PA; Janice M. Mehnert, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Alain Algazi, University of California, San Francisco, San Francisco, CA; Sanatan Saraf, Pradeep Thanigaimani, and Jonathan D. Cheng, Merck & Co., Inc., Kenilworth, NJ; Caroline Even, Gustave Roussy, Villejuif; Christophe Le Tourneau, Institut Curie, Paris; Christophe Le Tourneau, INSERM U900 Research Unit, Saint-Cloud, France; Emilie M.J. van Brummelen, Netherlands Cancer Institute, Amsterdam, the Netherlands; and Aaron R. Hansen, Princess Margaret Cancer Centre, Toronto, ON, Canada.; Even C; Chiun Hsu, National Taiwan University Hospital, Graduate Institute of Oncology, National Taiwan University College of Medicine, and National Taiwan University Cancer Center, Taipei, Taiwan, Republic of China; Se-Hoon Lee, Seoul National University Hospital, Seoul, South Korea; Samuel Ejadi, Virginia G. Piper Cancer Center, Scottsdale, AZ; Roger B. Cohen, University of Pennsylvania, Philadelphia, PA; Janice M. Mehnert, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Alain Algazi, University of California, San Francisco, San Francisco, CA; Sanatan Saraf, Pradeep Thanigaimani, and Jonathan D. Cheng, Merck & Co., Inc., Kenilworth, NJ; Caroline Even, Gustave Roussy, Villejuif; Christophe Le Tourneau, Institut Curie, Paris; Christophe Le Tourneau, INSERM U900 Research Unit, Saint-Cloud, France; Emilie M.J. van Brummelen, Netherlands Cancer Institute, Amsterdam, the Netherlands; and Aaron R. Hansen, Princess Margaret Cancer Centre, Toronto, ON, Canada.; Cohen RB; Chiun Hsu, National Taiwan University Hospital, Graduate Institute of Oncology, National Taiwan University College of Medicine, and National Taiwan University Cancer Center, Taipei, Taiwan, Republic of China; Se-Hoon Lee, Seoul National University Hospital, Seoul, South Korea; Samuel Ejadi, Virginia G. Piper Cancer Center, Scottsdale, AZ; Roger B. Cohen, University of Pennsylvania, Philadelphia, PA; Janice M. Mehnert, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Alain Algazi, University of California, San Francisco, San Francisco, CA; Sanatan Saraf, Pradeep Thanigaimani, and Jonathan D. Cheng, Merck & Co., Inc., Kenilworth, NJ; Caroline Even, Gustave Roussy, Villejuif; Christophe Le Tourneau, Institut Curie, Paris; Christophe Le Tourneau, INSERM U900 Research Unit, Saint-Cloud, France; Emilie M.J. van Brummelen, Netherlands Cancer Institute, Amsterdam, the Netherlands; and Aaron R. Hansen, Princess Margaret Cancer Centre, Toronto, ON, Canada.; Le Tourneau C; Chiun Hsu, National Taiwan University Hospital, Graduate Institute of Oncology, National Taiwan University College of Medicine, and National Taiwan University Cancer Center, Taipei, Taiwan, Republic of China; Se-Hoon Lee, Seoul National University Hospital, Seoul, South Korea; Samuel Ejadi, Virginia G. Piper Cancer Center, Scottsdale, AZ; Roger B. Cohen, University of Pennsylvania, Philadelphia, PA; Janice M. Mehnert, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Alain Algazi, University of California, San Francisco, San Francisco, CA; Sanatan Saraf, Pradeep Thanigaimani, and Jonathan D. Cheng, Merck & Co., Inc., Kenilworth, NJ; Caroline Even, Gustave Roussy, Villejuif; Christophe Le Tourneau, Institut Curie, Paris; Christophe Le Tourneau, INSERM U900 Research Unit, Saint-Cloud, France; Emilie M.J. van Brummelen, Netherlands Cancer Institute, Amsterdam, the Netherlands; and Aaron R. Hansen, Princess Margaret Cancer Centre, Toronto, ON, Canada.; Mehnert JM; Chiun Hsu, National Taiwan University Hospital, Graduate Institute of Oncology, National Taiwan University College of Medicine, and National Taiwan University Cancer Center, Taipei, Taiwan, Republic of China; Se-Hoon Lee, Seoul National University Hospital, Seoul, South Korea; Samuel Ejadi, Virginia G. Piper Cancer Center, Scottsdale, AZ; Roger B. Cohen, University of Pennsylvania, Philadelphia, PA; Janice M. Mehnert, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Alain Algazi, University of California, San Francisco, San Francisco, CA; Sanatan Saraf, Pradeep Thanigaimani, and Jonathan D. Cheng, Merck & Co., Inc., Kenilworth, NJ; Caroline Even, Gustave Roussy, Villejuif; Christophe Le Tourneau, Institut Curie, Paris; Christophe Le Tourneau, INSERM U900 Research Unit, Saint-Cloud, France; Emilie M.J. van Brummelen, Netherlands Cancer Institute, Amsterdam, the Netherlands; and Aaron R. Hansen, Princess Margaret Cancer Centre, Toronto, ON, Canada.; Algazi A; Chiun Hsu, National Taiwan University Hospital, Graduate Institute of Oncology, National Taiwan University College of Medicine, and National Taiwan University Cancer Center, Taipei, Taiwan, Republic of China; Se-Hoon Lee, Seoul National University Hospital, Seoul, South Korea; Samuel Ejadi, Virginia G. Piper Cancer Center, Scottsdale, AZ; Roger B. Cohen, University of Pennsylvania, Philadelphia, PA; Janice M. Mehnert, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Alain Algazi, University of California, San Francisco, San Francisco, CA; Sanatan Saraf, Pradeep Thanigaimani, and Jonathan D. Cheng, Merck & Co., Inc., Kenilworth, NJ; Caroline Even, Gustave Roussy, Villejuif; Christophe Le Tourneau, Institut Curie, Paris; Christophe Le Tourneau, INSERM U900 Research Unit, Saint-Cloud, France; Emilie M.J. van Brummelen, Netherlands Cancer Institute, Amsterdam, the Netherlands; and Aaron R. Hansen, Princess Margaret Cancer Centre, Toronto, ON, Canada.; van Brummelen EMJ; Chiun Hsu, National Taiwan University Hospital, Graduate Institute of Oncology, National Taiwan University College of Medicine, and National Taiwan University Cancer Center, Taipei, Taiwan, Republic of China; Se-Hoon Lee, Seoul National University Hospital, Seoul, South Korea; Samuel Ejadi, Virginia G. Piper Cancer Center, Scottsdale, AZ; Roger B. Cohen, University of Pennsylvania, Philadelphia, PA; Janice M. Mehnert, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Alain Algazi, University of California, San Francisco, San Francisco, CA; Sanatan Saraf, Pradeep Thanigaimani, and Jonathan D. Cheng, Merck & Co., Inc., Kenilworth, NJ; Caroline Even, Gustave Roussy, Villejuif; Christophe Le Tourneau, Institut Curie, Paris; Christophe Le Tourneau, INSERM U900 Research Unit, Saint-Cloud, France; Emilie M.J. van Brummelen, Netherlands Cancer Institute, Amsterdam, the Netherlands; and Aaron R. Hansen, Princess Margaret Cancer Centre, Toronto, ON, Canada.; Saraf S; Chiun Hsu, National Taiwan University Hospital, Graduate Institute of Oncology, National Taiwan University College of Medicine, and National Taiwan University Cancer Center, Taipei, Taiwan, Republic of China; Se-Hoon Lee, Seoul National University Hospital, Seoul, South Korea; Samuel Ejadi, Virginia G. Piper Cancer Center, Scottsdale, AZ; Roger B. Cohen, University of Pennsylvania, Philadelphia, PA; Janice M. Mehnert, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Alain Algazi, University of California, San Francisco, San Francisco, CA; Sanatan Saraf, Pradeep Thanigaimani, and Jonathan D. Cheng, Merck & Co., Inc., Kenilworth, NJ; Caroline Even, Gustave Roussy, Villejuif; Christophe Le Tourneau, Institut Curie, Paris; Christophe Le Tourneau, INSERM U900 Research Unit, Saint-Cloud, France; Emilie M.J. van Brummelen, Netherlands Cancer Institute, Amsterdam, the Netherlands; and Aaron R. Hansen, Princess Margaret Cancer Centre, Toronto, ON, Canada.; Thanigaimani P; Chiun Hsu, National Taiwan University Hospital, Graduate Institute of Oncology, National Taiwan University College of Medicine, and National Taiwan University Cancer Center, Taipei, Taiwan, Republic of China; Se-Hoon Lee, Seoul National University Hospital, Seoul, South Korea; Samuel Ejadi, Virginia G. Piper Cancer Center, Scottsdale, AZ; Roger B. Cohen, University of Pennsylvania, Philadelphia, PA; Janice M. Mehnert, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Alain Algazi, University of California, San Francisco, San Francisco, CA; Sanatan Saraf, Pradeep Thanigaimani, and Jonathan D. Cheng, Merck & Co., Inc., Kenilworth, NJ; Caroline Even, Gustave Roussy, Villejuif; Christophe Le Tourneau, Institut Curie, Paris; Christophe Le Tourneau, INSERM U900 Research Unit, Saint-Cloud, France; Emilie M.J. van Brummelen, Netherlands Cancer Institute, Amsterdam, the Netherlands; and Aaron R. Hansen, Princess Margaret Cancer Centre, Toronto, ON, Canada.; Cheng JD; Chiun Hsu, National Taiwan University Hospital, Graduate Institute of Oncology, National Taiwan University College of Medicine, and National Taiwan University Cancer Center, Taipei, Taiwan, Republic of China; Se-Hoon Lee, Seoul National University Hospital, Seoul, South Korea; Samuel Ejadi, Virginia G. Piper Cancer Center, Scottsdale, AZ; Roger B. Cohen, University of Pennsylvania, Philadelphia, PA; Janice M. Mehnert, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Alain Algazi, University of California, San Francisco, San Francisco, CA; Sanatan Saraf, Pradeep Thanigaimani, and Jonathan D. Cheng, Merck & Co., Inc., Kenilworth, NJ; Caroline Even, Gustave Roussy, Villejuif; Christophe Le Tourneau, Institut Curie, Paris; Christophe Le Tourneau, INSERM U900 Research Unit, Saint-Cloud, France; Emilie M.J. van Brummelen, Netherlands Cancer Institute, Amsterdam, the Netherlands; and Aaron R. Hansen, Princess Margaret Cancer Centre, Toronto, ON, Canada.; Hansen AR; Chiun Hsu, National Taiwan University Hospital, Graduate Institute of Oncology, National Taiwan University College of Medicine, and National Taiwan University Cancer Center, Taipei, Taiwan, Republic of China; Se-Hoon Lee, Seoul National University Hospital, Seoul, South Korea; Samuel Ejadi, Virginia G. Piper Cancer Center, Scottsdale, AZ; Roger B. Cohen, University of Pennsylvania, Philadelphia, PA; Janice M. Mehnert, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Alain Algazi, University of California, San Francisco, San Francisco, CA; Sanatan Saraf, Pradeep Thanigaimani, and Jonathan D. Cheng, Merck & Co., Inc., Kenilworth, NJ; Caroline Even, Gustave Roussy, Villejuif; Christophe Le Tourneau, Institut Curie, Paris; Christophe Le Tourneau, INSERM U900 Research Unit, Saint-Cloud, France; Emilie M.J. van Brummelen, Netherlands Cancer Institute, Amsterdam, the Netherlands; and Aaron R. Hansen, Princess Margaret Cancer Centre, Toronto, ON, Canada.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] van Brummelen, Emilie M.J.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어